Cost-Utility Analysis of Rhtnk-TPA Compared With RT-PA In The Treatment of Acute St-Segment Elevation Myocardial Infarction (Stemi) In China
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1246
https://www.valueinhealthjournal.com/article/S1098-3015(17)31580-2/fulltext
Title :
Cost-Utility Analysis of Rhtnk-TPA Compared With RT-PA In The Treatment of Acute St-Segment Elevation Myocardial Infarction (Stemi) In China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31580-2&doi=10.1016/j.jval.2017.08.1246
First page :
A618
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1191